论文信息 - Rationale and design of the German-Speaking Myeloma Multicenter Group (GMMG) trial ReLApsE: a randomized, open, multicenter phase III trial of lenalidomide/dexamethasone versus lenalidomide/dexamethasone plus subsequent autologous stem cell transplantation and lenalidomide maintenance in patients wi - 字舞流文

Rationale and design of the German-Speaking Myeloma Multicenter Group (GMMG) trial ReLApsE: a randomized, open, multicenter phase III trial of lenalidomide/dexamethasone versus lenalidomide/dexamethasone plus subsequent autologous stem cell transplantation and lenalidomide maintenance in patients wi

D. Hose | H. Goldschmidt | A. Jauch | T. Hielscher | I. Schmidt-Wolf | M. Merz | C. Kunz | C. Scheid | R. Fenk | S. Luntz | U. Graeven | J. Hillengass | H. Salwender | M. Raab | E. Mai | K. Weisel | P. Wuchter | A. Nogai | R. Noppeney | S. Klein | H. Lindemann | H. Martin | M. Baertsch | M. Goerner | Jana Schlenzka | M. Schmidt-Hieber | P. Reimer | Mathias Haenel | A. D. Ho